Bristol-Myers Squibb Selects Veeva Vault RIM Solutions

Bristol-Myers Squibb Selects Veeva Vault RIM Solutions
Veeva Vault RIM unites headquarters and local affiliates onto a shared global system, creating a single source for product registration information, regulatory correspondence, and archived submissions

February 29, 2016 07:03 AM Eastern Standard Time
PLEASANTON, Calif.--(BUSINESS WIRE)--Veeva today announced that Bristol-Myers Squibb (NYSE: BMY) has selected Veeva Vault Registrations and Veeva Vault SubmissionsArchive, two next generation regulatory solutions from the Vault RIM suite, to manage registration tracking and submission archiving globally.

The Vault RIM suite allows life sciences companies to align regulatory processes worldwide, improving speed, agility, and compliance. With Vault RIM companies have real-time access to submission plans, product registration status, health authority correspondence and commitments, and local market submissions. The resulting visibility streamlines global processes and improves data quality, helping companies respond faster to business changes.

"Life sciences companies struggle to manage product submissions and registration information around the world," said John Lawrie, director of Veeva Vault RIM. "Veeva understands the breadth of this challenge and has introduced a unified solution that helps harmonize global operations and provides the visibility organizations need to manage their product portfolio more effectively."

Vault RIM is part of Veeva Vault, the first cloud-based regulated content management platform and suite of applications designed for life sciences. The Veeva Vault family of applications span clinical, quality, commercial, medical, and regulatory to ensure one trusted source for content and data across the enterprise.

Additional Information

For more on Veeva Vault RIM, visit:
Stay updated on the latest Veeva news on LinkedIn:
Follow @veevasystems on Twitter:
Like Veeva on Facebook:

About Veeva Vault

Veeva Vault is the first cloud-based regulated content management platform and suite of applications designed for life sciences. It spans clinical, quality, commercial, medical, regulatory, and every major part of a global life sciences company to ensure one trusted source for content and data across the enterprise. Helping companies connect securely in the life sciences cloud, Vault provides complete control from start to finish, as well as the easy accessibility, visibility, and agility needed to speed time to market. All Vault applications offer real-time reporting and dashboards; an intuitive, consumer-web interface; and a true multitenant cloud architecture that continuously delivers rapid innovation. Today, more than 190 customers rely upon Vault to manage their most important content.

About Veeva Systems

Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 375 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit

Forward-looking Statements

This release contains forward-looking statements, including the market demand for and acceptance of Veeva's products and services, the results from use of Veeva's products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva's historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva's expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva's financial results are included under the captions, "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's filing on Form 10-Q for the period ended October 31, 2015. This is available on the company's website at under the Investors section and on the SEC's website at Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.

Veeva Systems Inc.
Lisa Barbadora
Public Relations
[email protected]

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.